Morgan Stanley (MS) 13D/13G Filings for Praxis Precision Medicines, Inc. (PRAX)

Morgan Stanley 13D and 13G filings for Praxis Precision Medicines, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-02-05
10:10 am
Purchase
2024-12-3113GPraxis Precision Medicines, Inc.
PRAX
MORGAN STANLEY
MS
1,157,140
6.200%
1,157,140increase
(New Position)
Filing